Company Filing History:
Years Active: 1991
Title: John P. Adelman: Innovator in Polypeptide Hormone Research
Introduction
John P. Adelman is a notable inventor based in Eugene, Oregon. He has made significant contributions to the field of biotechnology, particularly in the area of polypeptide hormones. His work has implications for both therapeutic and diagnostic applications.
Latest Patents
Adelman holds a patent for the invention titled "Prepro-LHRH C-terminal peptide DNA." This patent identifies DNA encoding a novel polypeptide hormone, designated CTP, which has been found in the human genome. CTP is expressed as a fusion protein with luteinizing hormone releasing hormone (LHRH) and is processed to yield both CTP and LHRH. The applications of CTP, its derivatives, and its fusions, including proLHRH, are valuable in various therapeutic and diagnostic contexts. He has 1 patent to his name.
Career Highlights
John P. Adelman has had a distinguished career, working at Genentech, Inc., a leading biotechnology company. His research has contributed to advancements in understanding hormone functions and their potential applications in medicine.
Collaborations
Adelman has collaborated with notable scientists in his field, including Peter H. Seeburg. These collaborations have furthered research in polypeptide hormones and their therapeutic uses.
Conclusion
John P. Adelman's innovative work in polypeptide hormone research exemplifies the impact of biotechnology on medicine. His contributions continue to influence therapeutic and diagnostic advancements in the field.